The role of hypoxia-inducible factors in tumorigenesis

Rankin, E B, Giaccia, A J·2008·Cell Death & Differentiation

DOI 10.1038/cdd.2008.21

Cited by (808)

Items 101–200 of 808

Hypoxia, angiogenesis and liver fibrogenesis in the progression of chronic liver diseases
Claudia Paternostro · 2010 · World Journal of Gastroenterology
N 6 -methyladenosine is required for the hypoxic stabilization of specific mRNAs
Nate J. Fry, Brittany A. Law, Olga Ilkayeva, Christopher L. Holley, Kyle D. Mansfield · 2017 · RNA
Role of hypoxia-inducible factors (HIF) in the maintenance of stemness and malignancy of colorectal cancer
Ramakrishna Vadde, Vemula Sarojamma, Rajeswari Jinka, Neha Merchant, Pallaval Veera Bramhachari, Ganji Purnachandra Nagaraju · 2017 · Critical Reviews in Oncology/Hematology
Inflammatory interferon activates HIF-1α-mediated epithelial-to-mesenchymal transition via PI3K/AKT/mTOR pathway
Yen-Hsiu Yeh, Ho-Fu Hsiao, Yen-Cheng Yeh, Tien-Wen Chen, Tsai‐Kun Li · 2018 · Journal of Experimental & Clinical Cancer Research
The m 6 A RNA demethylase FTO is a HIF-independent synthetic lethal partner with the VHL tumor suppressor
Yiren Xiao, Kaushik N. Thakkar, Hongjuan Zhao, James P. Broughton, Yang Li, José Antonio Seoane, Anh N. Diep, Thomas J. Metzner, Rie von Eyben, David L. Dill et al. · 2020 · Proceedings of the National Academy of Sciences
Angiogenesis and Multiple Myeloma
Nicola Giuliani, Paola Storti, Marina Bolzoni, Benedetta Dalla Palma, Sabrina Bonomini · 2011 · Cancer Microenvironment
Therapeutic Delivery of siRNA Silencing HIF-1 Alpha with Micellar Nanoparticles Inhibits Hypoxic Tumor Growth
Xi‐Qiu Liu, Menghua Xiong, Xiaoting Shu, Rui-Zhi Tang, Jun Wang · 2012 · Molecular Pharmaceutics
The Role of Vitamin D in Cancer Prevention and Treatment
Aruna V. Krishnan, Donald L. Trump, Candace S. Johnson, David Feldman · 2012 · Rheumatic Disease Clinics of North America
Targeting hypoxic tumour cells to overcome metastasis
Bennewith, Kevin L, Dedhar, Shoukat · 2011 · BMC Cancer
Post-Transcriptional Control of the Hypoxic Response by RNA-Binding Proteins and MicroRNAs
Myriam Gorospe, Kumiko Tominaga, Xue Wu, Michael Fähling, Mircea Ivan · 2011 · Frontiers in Molecular Neuroscience
Hypoxia-Inducible Aryl Hydrocarbon Receptor Nuclear Translocator (ARNT) (HIF-1β): Is It a Rare Exception?
Markus Mandl, Reinhard Depping · 2014 · Molecular Medicine
Oxidative stress in carcinogenesis
James E. Klaunig, Zemin Wang · 2017 · Current Opinion in Toxicology
CDK1 stabilizes HIF-1α via direct phosphorylation of Ser668 to promote tumor growth
Noel A. Warfel, Nathan G. Dolloff, David T. Dicker, Jozef Malysz, Wafik S. El‐Deiry · 2013 · Cell Cycle
Hypoxia-inducible factor (HIF)-1α suppression in myeloma cells blocks tumoral growth in vivo inhibiting angiogenesis and bone destruction
Paola Storti, Marina Bolzoni, Gaetano Donofrío, Irma Airoldi, Daniela Guasco, Denise Toscani, E Martella, Mirca Lazzaretti, C Mancini, Luca Agnelli et al. · 2013 · Leukemia
Elimination of head and neck cancer initiating cells through targeting glucose regulated protein78 signaling
Meng‐Ju Wu, Chia-Ing Jan, Yeou‐Guang Tsay, Yau‐Hua Yu, Chih‐Yang Huang, Shu‐Chun Lin, Chung‐Ji Liu, Yu−Syuan Chen, Jeng‐Fan Lo, Cheng-Chia Yu · 2010 · Molecular Cancer
Angiogenesis and expression of PDGF ‐ C , VEGF , CD 105 and HIF ‐1α in human glioblastoma
Carlos Clara, Suely Kazue Nagahashi Marie, J.R.W. Almeida, Alda Wakamatsu, Sueli Mieko Oba‐Shinjo, Miyuki Uno, Munro A. Neville, Sérgio Rosemberg · 2014 · Neuropathology
Hypoxia Enhances Sphingosine Kinase 2 Activity and Provokes Sphingosine-1-Phosphate-Mediated Chemoresistance in A549 Lung Cancer Cells
Steffen E. Schnitzer, Andreas Weigert, Jie Zhou, Bernhard Brüne · 2009 · Molecular Cancer Research
The controversial place of vitamin C in cancer treatment
Julien Verrax, Pedro Buc Calderón · 2008 · Biochemical Pharmacology
Aminoflavone, a Ligand of the Aryl Hydrocarbon Receptor, Inhibits HIF-1α Expression in an AhR-Independent Fashion
Terzuoli, Erika, Puppo, Maura, Rapisarda, Annamaria, Uranchimeg, Badarch, Cao, Liang, Burger, Angelika M., Ziche, Marina, Melillo, Giovanni · 2010 · Cancer Research
Development of mitochondria-targeted derivatives of resveratrol
Lucia Biasutto, Andrea Mattarei, Ester Marotta, Alice Bradaschia, Nicola Sassi A, Spiridione Garbisa, Mario Zoratti, Cristina Paradisi · 2008 · Bioorganic & Medicinal Chemistry Letters
Advances in targeted therapy mainly based on signal pathways for nasopharyngeal carcinoma
Yuanbo Kang, Weihan He, Caiping Ren, Jincheng Qiao, Qiuyong Guo, Jingyu Hu, Hongjuan Xu, Xingjun Jiang, Lei Wang · 2020 · Signal Transduction and Targeted Therapy
The Role of Hypoxia in Glioblastoma Radiotherapy Resistance
Agathe L. Chédeville, Patrícia A. Madureira · 2021 · Cancers
Lipoxin A4 and Its Analogue Suppress the Tumor Growth of Transplanted H22 in Mice: The Role of Antiangiogenesis
Ying Chen, Hua Hao, Songqing He, Lei Cai, Yongsheng Li, Shunze Hu, Duyun Ye, John R. Hoidal, Ping Wu, Xiaoping Chen · 2010 · Molecular Cancer Therapeutics
Hypoxia signaling and resistance in C. elegans
Jo Anne Powell‐Coffman · 2010 · Trends in Endocrinology and Metabolism
A biology-driven approach identifies the hypoxia gene signature as a predictor of the outcome of neuroblastoma patients
Paolo Fardin, Annalisa Barla, Sofia Mosci, Lorenzo Rosasco, Alessandro Verri, Rogier Versteeg, Huib N. Caron, Jan J. Molenaar, Ingrid Øra, Alessandra Eva et al. · 2010 · Molecular Cancer
<scp>HIF</scp> 3α: the little we know
Ravenna, Linda, Salvatori, Luisa, Russo, Matteo A. · 2016 · The FEBS Journal
From signalling pathways to targeted therapies: unravelling glioblastoma’s secrets and harnessing two decades of progress
Brittany Dewdney, Misty Rayna Jenkins, Sarah A. Best, Saskia Freytag, Krishneel Prasad, Jeff Holst, Raelene Endersby, Terrance G. Johns · 2023 · Signal Transduction and Targeted Therapy
The LIMD1 protein bridges an association between the prolyl hydroxylases and VHL to repress HIF-1 activity
Daniel E. Foxler, Katherine S. Bridge, Victoria H. James, Thomas M. Webb, Maureen Mee, Sybil C.K. Wong, Yunfeng Feng, Dumitru Constantin‐Teodosiu, Thorgunnur Eyfjord Petursdottir, Jóhannes Björnsson et al. · 2012 · Nature Cell Biology
Hypoxia-mediated regulation of macrophage functions in pathophysiology
Elena Riboldi, Chiara Porta, Sara Morlacchi, Antonella Viola, Alberto Mantovani, Antonio Sica · 2012 · International Immunology
Proliferation of Immature Tumor Vessels Is a Novel Marker of Clinical Progression in Prostate Cancer
Karsten Gravdal, OLE JOHAN HALVORSEN, Svein Andreas Haukaas, Lars A. Akslen · 2009 · Cancer Research
The Akt1-eNOS Axis Illustrates the Specificity of Kinase-Substrate Relationships in Vivo
Michael Schleicher, Jun Yu, Takahisa Murata, Berhad Derakhshan, Dmitriy N. Atochin, Li Qian, Satoshi Kashiwagi, Annarita Di Lorenzo, Kenneth D. Harrison, Paul Lee Huang et al. · 2009 · Science Signaling
Nanomedicine Strategies in Conquering and Utilizing the Cancer Hypoxia Environment
Yi Pan, Longcai Liu, Xiaozhou Mou, Yu Cai · 2023 · ACS Nano
Targeting VEGF-A/VEGFR2 Y949 Signaling-Mediated Vascular Permeability Alleviates Hypoxic Pulmonary Hypertension
Weibin Zhou, Keli Liu, Lei Zeng, Jiaqi He, Xinbo Gao, Xinyu Gu, Xun Chen, Jing Jing Li, Minghui Wang, Duoguang Wu et al. · 2022 · Circulation
Emerging evidence of epithelial‐to‐mesenchymal transition in lung carcinogenesis
Mitsuo Sato, David S. Shames, Yoshinori Hasegawa · 2012 · Respirology
Sleep apnea increased incidence of primary central nervous system cancers: a nationwide cohort study
Chen, Jin-Cherng, Hwang, Juen-Haur · 2014 · Sleep Medicine
A Central Role for Hypoxic Signaling in Cartilage, Bone, and Hematopoiesis
Rankin, Erinn B., Giaccia, Amato J., Schipani, Ernestina · 2011 · Current Osteoporosis Reports
Targeting the Angiopoietin-2/Tie-2 axis in conjunction with VEGF signal interference
Nikolett M. Biel, Dietmar W. Siemann · 2014 · Cancer Letters
Up‐regulation of survivin by AKT and hypoxia‐inducible factor 1α contributes to cisplatin resistance in gastric cancer
Xuepu Sun, Xuesong Dong, Lele Lin, Xian Li Jiang, Zheng Wei, Bo Zhai, Bo Sun, Qiang Zhang, Xiaolong Wang, Hongchi Jiang et al. · 2013 · FEBS Journal
Intermittent hypoxia is an angiogenic inducer for endothelial cells: role of HIF-1
Sébastien Toffoli, Audrey Roegiers, Olivier Féron, Martine Van Steenbrugge, Noëlle Ninane, Martine J. Raes, Carine Michiels · 2009 · Angiogenesis
Hyperbaric Oxygen Potentiates Doxil Antitumor Efficacy by Promoting Tumor Penetration and Sensitizing Cancer Cells
Xian Guo Wu, Yanhong Zhu, Wei Huang, Jingqiu Li, Bixiang Zhang, Zifu Li, Xiangliang Yang · 2018 · Advanced Science
Tumor suppressor WWOX regulates glucose metabolism via HIF1α modulation
Muhannad Abu‐Remaileh, Rami I. Aqeilan · 2014 · Cell Death and Differentiation
2-Methoxyestradiol synergizes with sorafenib to suppress hepatocellular carcinoma by simultaneously dysregulating hypoxia-inducible factor-1 and -2
Li Ma, Guangxin Li, Huaqiang Zhu, Xuesong Dong, Dali Zhao, Xian Li Jiang, Jie Li, Haiquan Qiao, Shaobin Ni, Xueying Sun · 2014 · Cancer Letters
Novel Drugs with High Efficacy against Tumor Angiogenesis
Shiyu Qi, Shoulong Deng, Zhengxing Lian, Kun Yu · 2022 · International Journal of Molecular Sciences
Hypoxia activates Wnt/β-catenin signaling by regulating the expression of BCL9 in human hepatocellular carcinoma
Xu, Wei, Zhou, Wang, Cheng, Mo, Wang, Jing, Liu, Zhian, He, Shaohui, Luo, Xiangji, Huang, Wending, Chen, Tianrui, Yan, Wangjun et al. · 2017 · Scientific Reports
Stanniocalcin-2 promotes epithelial–mesenchymal transition and invasiveness in hypoxic human ovarian cancer cells
Alice Yu Sheung Law, Chris K.C. Wong · 2010 · Experimental Cell Research
In vivo Dynamics and Distinct Functions of Hypoxia in Primary Tumor Growth and Organotropic Metastasis of Breast Cancer
Xin Lü, Carol H. Yan, Min Yuan, Yong Wei, Guohong Hu, Yibin Kang · 2010 · Cancer Research
Sevoflurane promotes the expansion of glioma stem cells through activation of hypoxia-inducible factors in vitro
Q.Y. Shi, S.J. Zhang, L. Liu, Q.S. Chen, Lina Yu, F.J. Zhang, Min Yan · 2014 · British Journal of Anaesthesia
Sequential pathogenesis of metastatic VHL mutant clear cell renal cell carcinoma: putting it together with a translational perspective
Niraj Konchady Shenoy, Lance C. Pagliaro · 2016 · Annals of Oncology
Metformin increases PDH and suppresses HIF-1α under hypoxic conditions and induces cell death in oral squamous cell carcinoma
Talita Antunes Guimarães, Lucyana Conceição Farias, Eliane Sobrinho Santos, Carlos Alberto de Carvalho Fraga, Lissur Azevedo Orsine, Leandro de Freitas Teles, John David Feltenberger, Sabrina Ferreira de Jesus, Marcela Gonçalves de Souza, Sérgio Henrique Sousa Santos et al. · 2016 · Oncotarget
MicroRNA‐155 targets theSKIgene in human melanoma cell lines
Lauretta Levati, Elena Pagani, Sveva Romani, Daniele Castiglia, Eugenia Piccinni, Claudia Covaciu, Patrizia Caporaso, Sergio Bondanza, Francesca Romana Antonetti, Enzo Bonmassar et al. · 2011 · Pigment Cell & Melanoma Research
Conditional HIF-1 induction produces multistage neovascularization with stage-specific sensitivity to VEGFR inhibitors and myeloid cell independence
Sunday S. Oladipupo, Song Hu, Andrea C. Santeford, Junjie Yao, Joanna R. Kovalski, Ralph V. Shohet, Konstantin Maslov, Lihong V. Wang, Jeffrey M. Arbeit · 2011 · Blood
Contribution of the Type II Chaperonin, TRiC/CCT, to Oncogenesis
Soung‐Hun Roh, Moses M. Kasembeli, Deenadayalan Bakthavatsalam, Wah Chiu, David John Tweardy · 2015 · International Journal of Molecular Sciences
Heme oxygenase 1 (HO-1) challenges the angiogenic switch in prostate cancer
Mercedes Ferrando, Geraldine Gueron, Belén Elguero, Jimena Giudice, Angeles Salles, Federico Coluccio Leskow, Elizabeth Andrea Jares-Erijman, Lucas Luis Colombo, Roberto Pablo Meiss, Nora Maria Navone et al. · 2011 · Angiogenesis
Adverse reactions to targeted and non-targeted chemotherapeutic drugs with emphasis on hypersensitivity responses and the invasive metastatic switch
Brian A. Baldo, Nghia H. Pham · 2013 · Cancer and Metastasis Reviews
Follow the ATP: Tumor Energy Production: A Perspective
Bryan T. Oronsky, Neil C. Oronsky, Gary R. Fanger, Christopher T. Parker, Scott Z. Caroen, Michelle Lybeck, Jan J. Scicinski · 2014 · Anti-Cancer Agents in Medicinal Chemistry
The twisted survivin connection to angiogenesis
Cristobal T. Sanhueza, Sergio Wehinger, J. Bennett, Manuel Valenzuela, Gareth I. Owen, Andrew F. G. Quest · 2015 · Molecular Cancer
A Group of Novel HIF‐1α Inhibitors, Glyceollins, Blocks HIF‐1α Synthesis and Decreases Its Stability via Inhibition of the PI3K/AKT/mTOR Pathway and Hsp90 Binding
Lee, Sun‐Hee, Jee, Jun‐Goo, Bae, Jong‐Sup, Liu, Kwang‐Hyoen, Lee, You Mie · 2015 · Journal of Cellular Physiology
Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells
Meng‐Chuan Chen, Chi-Feng Lee, Wen‐Hsin Huang, Tz‐Chong Chou · 2013 · Biochemical Pharmacology
The Ape‐1/Ref‐1 redox antagonist E3330 inhibits the growth of tumor endothelium and endothelial progenitor cells: Therapeutic implications in tumor angiogenesis
Gang-Ming Zou, Collins A. Karikari, Yasuaki Kabe, Hiroshi Handa, Robert A. Anders, Anirban Maitra · 2008 · Journal of Cellular Physiology
RNA‐binding proteins implicated in the hypoxic response
Kiyoshi Masuda, Kotb Abdelmohsen, Myriam Gorospe · 2009 · Journal of Cellular and Molecular Medicine
Mice with Inactivation of Aryl Hydrocarbon Receptor-Interacting Protein (Aip) Display Complete Penetrance of Pituitary Adenomas with Aberrant ARNT Expression
Anniina Raitila, Heli J. Lehtonen, Johanna T. Arola, Elina Heliövaara, Manuel Ahlsten, Marianthi Georgitsi, Anu Jalanko, Anders E. Paetau, Lauri A. Aaltonen, Auli Karhu · 2010 · American Journal Of Pathology
RETRACTED ARTICLE: hERG1 channels modulate integrin signaling to trigger angiogenesis and tumor progression in colorectal cancer
Olivia Crociani, Francesca Zanieri, Serena Pillozzi, Elena Lastraioli, Matteo Stefanini, Antonella Fiore, Angelo Fortunato, Massimo D’Amico, Marika Masselli, Emanuele De Lorenzo et al. · 2013 · Scientific Reports · Retracted
CXCR7 is up-regulated in human and murine hepatocellular carcinoma and is specifically expressed by endothelial cells
Justin Monnier, Mathieu Boissan, Annie L’Helgoualc’h, Marie‐Lise Lacombe, Bruno Turlin, Jessica Zucman‐Rossi, Nathalie Théret, Claire Piquet‐Pellorce, Michel Samson · 2011 · European Journal of Cancer
Hypoxia inducible factor 2 alpha inhibits hepatocellular carcinoma growth through the transcription factor dimerization partner 3/ E2F transcription factor 1–dependent apoptotic pathway
Hai-Xiang Sun, Yang Xu, Xin‐Rong Yang, Weimin Wang, Haibo Bai, Ruo-Yu Shi, Suresh K. Nayar, Ranjan Prasad Devbhandari, Yi-zhou He, Qin-Feng Zhu et al. · 2012 · Hepatology
CTGF is a therapeutic target for metastatic melanoma
Elizabeth C. Finger, C-F Cheng, Thomas Robert Williams, Erinn B. Rankin, Barbara Bedogni, Lisa May Ling Tachiki, Suzanne M. Spong, Amato J. Giaccia, Marianne Broome Powell · 2013 · Oncogene
Impact of Heat-Shock Protein 90 on Cancer Metastasis
Shinji Tsutsumi, Kristin E. Beebe, Len Neckers · 2009 · Future Oncology
Activation of Peroxisome Proliferator-activated Receptor α (PPARα) Suppresses Hypoxia-inducible Factor-1α (HIF-1α) Signaling in Cancer Cells
Jundong Zhou, Shuyu Zhang, Jing Xue, Jori E. Avery, Jinchang Wu, Stuart E. Lind, Wei‐Qun Ding · 2012 · Journal of Biological Chemistry
Coexpression of hypoxia-inducible factor-1α and glucose transporter-1 is associated with poor prognosis in oral squamous cell carcinoma patients
Alexander W. Eckert, M.H.W. Lautner, Andreas Schütze, Helge W. Taubert, Johannes Schubert, Udo Bilkenroth · 2011 · Histopathology
HIF prolyl hydroxylase inhibitors for anemia
Eugene Muchnik, Joshua Kaplan · 2011 · Expert Opinion on Investigational Drugs
The role of mucosal barriers in human gut health
Kangseok Seo, Jeong-Mi Seo, Jiyoun Yeun, Haebin Choi, Young‐In Kim, Sun-Young Chang · 2021 · Archives of Pharmacal Research
PHD3 regulates differentiation, tumour growth and angiogenesis in pancreatic cancer
Yun Yan Su, Martin Loos, Nathalia A. Giese, Oscar Joe Hines, Isabel Diebold, Agnes Görlach, Eric Metzen, Silvia Pastoreková, Helmut Frieß, Peter Büchler · 2010 · British Journal of Cancer
Correlation of biological aggressiveness assessed by 11C-methionine PET and hypoxic burden assessed by 18F-fluoromisonidazole PET in newly diagnosed glioblastoma
Nobuyuki Kawai, Yukito Maeda, Nobuyuki Kudomi, Keisuke Miyake, Masaki Okada, Yuka Yamamoto, Yoshihiro Nishiyama, Takashi Tamiya · 2010 · European Journal of Nuclear Medicine and Molecular Imaging
Hypoxia Modulates EWS-FLI1 Transcriptional Signature and Enhances the Malignant Properties of Ewing's Sarcoma Cells In vitro
Dave N.T. Aryee, Stephan Niedan, Maximilian O. Kauer, Raphaela Schwentner, Idriss M. Bennani-Baı̈ti, Jozef Ban, Karin Muehlbacher, Michael Kreppel, Robert L. Walker, Paul S. Meltzer et al. · 2010 · Cancer Research
Hypoxia-Induced Phenotypes that Mediate Tumor Heterogeneity
Jin Qian, Erinn B. Rankin · 2019 · Advances in experimental medicine and biology
Advances in the targeting of HIF-1α and future therapeutic strategies for glioblastoma multiforme
Gang Wang, Junjie Wang, Xingli Fu, Rui Guang, Shing-shun Tony To · 2016 · Oncology Reports
A redox-activated theranostic nanoagent: toward multi-mode imaging guided chemo-photothermal therapy
Tingting Zhang, Cong-Hui Xu, Wei Zhao, Yu Gu, Xiang‐Ling Li, Jing‐Juan Xu, Hong‐Yuan Chen · 2018 · Chemical Science
BODIPY-based probes for hypoxic environments
Lizhi Gai, Yanfei Liu, Zhikuan Zhou, Hua Lü, Zijian Guo · 2023 · Coordination Chemistry Reviews
Hypoxia upregulates ovarian cancer invasiveness via the binding of HIF‐1α to a hypoxia‐induced, methylation‐free hypoxia response element of S100A4 gene
Akiko Horiuchi, Takuma Hayashi, Norihiko Kikuchi, Akiko Hayashi, Chiho Fuseya, Tanri Shiozawa, Ikuo Konishi · 2012 · International Journal of Cancer
Redox Circuitries Driving Src Regulation
Elisa Giannoni, Paola Chiarugi · 2013 · Antioxidants and Redox Signaling
Recent Progress in the Design of Hypoxia‐Specific Nano Drug Delivery Systems for Cancer Therapy
Abhishek Sahu, Won Il Choi, Giyoong Tae · 2018 · Advanced Therapeutics
The Expression of AIP-Related Molecules in Elucidation of Cellular Pathways in Pituitary Adenomas
Elina Heliövaara, Anniina Raitila, Virpi Launonen, Anders E. Paetau, Johanna T. Arola, Heli J. Lehtonen, Timo Sane, Robert John Weil, Outi Kuismin, Pasi I. Salmela et al. · 2009 · American Journal Of Pathology
IGF binding protein‐6 expression in vascular endothelial cells is induced by hypoxia and plays a negative role in tumor angiogenesis
Zhang, Chunyang, Lu, Ling, Li, Yun, Wang, Xianlei, Zhou, Jianfeng, Liu, Yunzhang, Fu, Ping, Gallicchio, Marisa A., Bach, Leon A., Duan, Cunming · 2012 · International Journal of Cancer
Hypoxia-inducible factor in cancer: from pathway regulation to therapeutic opportunity
Ortmann, Brian M · 2024 · BMJ Oncology
Potent and sustained inhibition of HIF-1α and downstream genes by a polyethyleneglycol-SN38 conjugate, EZN-2208, results in anti-angiogenic effects
Sapra, Puja, Kraft, Patricia, Pastorino, Fabio, Ribatti, Domenico, Dumble, Melissa, Mehlig, Mary, Wang, Maoliang, Ponzoni, Mirco, Greenberger, Lee M., Horak, Ivan D. · 2011 · Angiogenesis
ZO Proteins and Redox-Dependent Processes
Lorenza González‐Mariscal, Miguel Quirós, Mónica Díaz-Coránguez · 2011 · Antioxidants and Redox Signaling
Delayed initiation of radiotherapy for glioblastoma: how important is it to push to the front (or the back) of the line?
Yaacov Richard Lawrence, Deborah T. Blumenthal, Diana Matceyevsky, Andrew A. Kanner, Felix Bokstein, Benjamin William Corn · 2011 · Journal of Neuro-Oncology
Clinicopathologic Significance of HIF‐1 α , CXCR4, and VEGF Expression in Colon Cancer
Yugang Wu, Min Jin, Huanbai Xu, Zhang Shimin, Songbing He, Liang Wang, Yanyun Zhang · 2010 · Journal of Immunology Research
Correlation of expression of hypoxia-related proteins with prognosis in oral squamous cell carcinoma patients
Alexander W. Eckert, Matthias Kappler, Johannes Schubert, Helge W. Taubert · 2012 · Oral and Maxillofacial Surgery
Hypoxia Inducible Factor 1α and Hypoxia Inducible Factor 2α Play Distinct and Functionally Overlapping Roles in Oral Squamous Cell Carcinoma
Guiquan Zhu, Ya‐ling Tang, Ling Li, Min Hua Zheng, Jian Dong Jiang, Xiaoyu Li, Si-xiu Chen, Xin‐hua Liang · 2010 · Clinical Cancer Research
Cancer as a Proinflammatory Environment: Metastasis and Cachexia
Nelson Inácio Pinto Neto, June Carnier, Lila Missae Oyama, José Pinhata Otoch, Paulo Sérgio Martins de Alcântara, Flávio Tokeshi, Cláudia Maria Oller do Nascimento · 2015 · Mediators of Inflammation
Nanoparticle‐Stabilized Oxygen Microcapsules Prepared by Interfacial Polymerization for Enhanced Oxygen Delivery
Baiheng Wu, Zhu Sun, Jiangchao Wu, Jian Ruan, Peng Zhao, Kai Liu, Chun‐Xia Zhao, Jianpeng Sheng, Tingbo Liang, Dong Chen · 2021 · Angewandte Chemie International Edition
Dual Hypoxia-Targeting RNAi Nanomedicine for Precision Cancer Therapy
Yujing Li, Jianxun Ding, Xiaoding Xu, Run Shi, Phei Er Saw, Junqing Wang, Shirley Chung, Wenliang Li, Bader Mubarak Aljaeid, Robert J. Lee et al. · 2020 · Nano Letters
Downregulating hypoxia‐inducible factor‐2α improves the efficacy of doxorubicin in the treatment of hepatocellular carcinoma
Changjun He, Xuepu Sun, Haiquan Qiao, Xian Jiang, Dongdong Wang, Xiangguo Jin, Xuesong Dong, Jizhou Wang, Hongchi Jiang, Xueying Sun · 2011 · Cancer Science
Hsp90 as a Gatekeeper of Tumor Angiogenesis: Clinical Promise and Potential Pitfalls
Jessica E. S. Bohonowych, Udhayakumar Gopal, Jennifer S. Isaacs · 2010 · Journal of Oncology
Andrographolide down-regulates hypoxia-inducible factor-1α in human non-small cell lung cancer A549 cells
Hui‐Hsuan Lin, Chia-Wen Tsai, Fen‐Pi Chou, Chau‐Jong Wang, Shu‐Wen Hsuan, Cheng-Kun Wang, Jing‐Hsien Chen · 2010 · Toxicology and Applied Pharmacology
Two Distinct Roles for EGL-9 in the Regulation of HIF-1-Mediated Gene Expression in Caenorhabditis elegans
Zhiyong Shao, Yi Zhang, Jo Anne Powell‐Coffman · 2009 · Genetics
The inhibition of hypoxia‐induced angiogenesis and metastasis by cinnamaldehyde is mediated by decreasing HIF‐1α protein synthesis via PI3K/Akt pathway
Kartick Patra, Samarjit Jana, Arnab Sarkar, Deba Prasad Mandal, Shamee Bhattacharjee · 2019 · BioFactors
Hypoxia-inducible factor-prolyl hydroxylase inhibitors for renal anemia in chronic kidney disease: Advantages and disadvantages
Akira Mima · 2021 · European Journal of Pharmacology
HILPDA promotes NASH-driven HCC development by restraining intracellular fatty acid flux in hypoxia
Davide Povero, Yongbin Chen, Scott M. Johnson, Cailin E. McMahon, Meixia Pan, Hanmei Bao, Xuan-Mai T. Petterson, Emily Blake, Kimberly P. Lauer, Daniel R. O’Brien et al. · 2023 · Journal of Hepatology
Hypoxia-Mediated Metastasis
Joan Chang, Janine Terra Erler · 2013 · Advances in experimental medicine and biology